Sigma Foods (SIGMAF) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 Apr, 2026Executive summary
Achieved record first-quarter volume and revenues, with comparable EBITDA up 18% year-over-year, mainly driven by Mexico and Europe, supported by disciplined execution and favorable FX dynamics.
2026 guidance reaffirmed and $150 million in cash dividends approved, reflecting a balanced approach to growth and shareholder returns.
Net income declined to $69 million from $192 million in 1Q25 due to a high comparison base from discontinued operations.
Investment-grade balance sheet with no material debt maturities in the next two years, supported by successful local note issuances.
Financial highlights
Revenues reached $2.372 billion, up 13% year-over-year, driven by favorable currency translation, selective price actions, and volume gains in Mexico, Europe, and Latin America.
Comparable EBITDA rose 18% year-over-year to $260 million, with margin improvement of 42 basis points.
Net debt totaled $2.832 billion at quarter-end, up 6% sequentially, mainly due to higher net working capital.
Operating income was $192 million, down 9% year-over-year.
Cash position at $512 million, with $908 million in available committed credit lines.
Outlook and guidance
2026 guidance remains unchanged, with external headwinds and tailwinds considered manageable and confidence in meeting full-year targets.
No material impact expected from the Iran conflict or oil price volatility, as most utilities in Europe are hedged and raw material trends are favorable.
Expect sequential improvement in U.S. EBITDA due to seasonality and better price-cost alignment.
Latest events from Sigma Foods
- Record revenues, margin expansion, Alpek spin-off, and strong 2026 outlook with increased dividends.SIGMAF
Q4 202512 Apr 2026 - Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - EBITDA and guidance rose on Sigma's record results, with debt reduction and transformation progressing.SIGMAF
Q2 20242 Feb 2026 - Sigma posts record EBITDA as ALFA advances Alpek spin-off and targets lower leverage.SIGMAF
Q3 202418 Jan 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025 - Transformation complete, 1Q25 EBITDA at US$220M, S&P upgrades to 'BBB'.SIGMAF
Q1 202529 Nov 2025 - Record 2Q25 revenues and EBITDA, with insurance gains and strategic transformation completed.SIGMAF
Q2 202513 Nov 2025